Vista Group Signs Enterprise Agreement with Odeon Cinemas Group – Europe’s Largest Cinema Operator
Vista Group International Ltd (NZX & ASX: VGL) is delighted to announce it has signed an agreement with Odeon Cinemas Group (‘ODEON’) to deliver solutions designed to transform guest journey engagement, influence and insight for ODEON. The combination of Vista’s cinema management software portfolio (‘Vista Cinema’), Movio Cinema big data analytics and marketing, Cinema Intelligence film forecasting and MX Film – real-time distribution of digital media assets – represents one of the most comprehensive roll-outs of Vista’s solutions ever undertaken.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190210005040/en/
ODEON, Europe’s largest cinema operator, with more than 360 cinemas located in 13 European countries, will deploy Vista across 120 cinema sites in the UK and Ireland.
The close integrations that exist between the Vista Group products have been recognised by ODEON as an opportunity to deploy a synergistic suite of software technology across their circuit. This is an approach to Vista deployments that will help ODEON meet their goals of providing an exceptional guest experience, whilst optimising their business operations via collaborative systems and homogeneity.
According to Odeon Cinemas Group CIO, Ian Chapple, “We’re delighted to have selected Vista Group as a strategic partner to assist us in transforming our guest experience at Odeon. We recognise the strength and depth of the Vista proposition and the experience that they bring will be key to helping us evolve our technology platforms and take the business to another level.”
“Beginning 2019 in collaboration with ODEON is the best Christmas present our team in EMEA could have wished for”, commented Mischa Kay, Managing Director of Vista Cinema, EMEA. “Aside from the importance of ODEON as a European powerhouse of exhibition, which adds to making our new partnership a total privilege, is the opportunity that Vista has, to excel in developing, managing and delivering cutting edge innovation through new products and services that span Vista Group companies.”
Vista Group CEO, Kimbal Riley is equally thrilled: “Our agreement with ODEON is a watershed moment for Vista Group”, he commented. “Our ability to deploy a wide-ranging integrated set of solutions for ODEON is a credit to the vision of our founders and to the capability of our teams across the business who imagine, design, develop and deploy technologies that delight our customers and enable the delight of their customers.”
The roll-out of the Vista solutions suite across ODEON UK and Ireland is expected to commence later this year.
About Vista Group
Vista Group International Ltd (Vista Group) is a public company, founded in New Zealand in the mid 1990’s and listed on both the New Zealand and Australian stock exchanges in 2014 (NZX & ASX: VGL). The Group provides software and additional technology solutions across the global film industry.
Cinema management software is provided by founding company Vista Entertainment Solutions (‘Vista Cinema’); Movio (the authority in moviegoer data analytics), Veezi (cloud-based software for the Independent Cinema Market), movieXchange (‘MX ‘ – connecting the movie industry to simplify the supply of film media for promotion and the sale of movie tickets), Maccs (film distribution software), Numero (box office reporting software for film distributors and cinemas), Cinema Intelligence (business intelligence solutions), Powster (creative studio and marketing platform for movie studios) and Flicks (moviegoer ‘go to’ portal for movie information), provide an innovative range of complementary products across additional film industry sectors, from production and distribution, to cinema exhibition through to the moviegoer experience.
Vista Group has offices located in New Zealand (Auckland HQ), Sydney, Cape Town, London, the Netherlands, Romania, Shanghai, Beijing, Los Angeles, and Mexico City.
About Odeon Cinemas Group
Odeon Cinemas Group is Europe's largest cinema operator, with leading positions and brands in the UK and Ireland, Spain, Italy, Sweden, Finland, Estonia, Latvia and Lithuania; and a strong presence in Norway, Germany and Portugal.
Odeon Cinemas Group is an AMC company; AMC is the largest movie exhibition company in the U.S., in Europe and throughout the world with more than 1,000 theatres and nearly 11,000 screens across the globe.
In Europe, Odeon Cinemas Group welcomes over 100 million guests each year to enjoy great hospitality while watching the latest films and entertainment in more than 360 cinemas and 2,900 screens. The Group is proud to be at the forefront of innovation by investing in fully reclining seats and offering a wide selection of food and beverage choices to create the ultimate guest experience.
For more information visit www.odeoncinemasgroup.com.
For Vista Group International/USA
Maggie Begley Communications, Los Angeles
Tel: +1 310 390.0101
For Vista Group International/UK
Branch Road, London
Tel: +44 (0) 203 189 1399
For Odeon Cinemas Group
Group Head of Communications, Odeon Cinemas Group
Tel: +44 (0) 20 7766 1809
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
c-LEcta: Successful Product Business in the First Half of 201922.8.2019 11:06:00 EEST | Press release
c-LEcta, a globally active biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully expanded its product business in the first half of 2019. Besides sales increases across the entire portfolio, the company was granted many new patents. While the patent portfolio still comprised 59 granted patents at the end of the first half of 2018, the Leipzig-based company now holds more than 80 patents. c-LEcta’s DENARASE®, which is used for the necessary removal of nucleic acids from biopharmaceutical products, performed particularly well. DENARASE® is the most efficient technology on the market for meeting the stringent regulatory requirements for biopharmaceutical products. Sales of this product increased by 164% year-on-year in the first half of 2019. The other products in c-LEcta’s portfolio also performed very well and contributed to the positive development of the product business. c-LEcta now markets its self-developed products in 25 co
MobileIron Named a Leader Again in the Second Gartner Magic Quadrant for Unified Endpoint Management Tools22.8.2019 10:00:00 EEST | Press release
MobileIron (NASDAQ:MOBL), the company that introduced the industry’s first mobile-centric, zero trust platform for the enterprise, today announced that it has been positioned as a Leader for the second consecutive year in the Gartner Magic Quadrant for Unified Endpoint Management Tools. The report evaluated 11 vendors based on completeness of vision and ability to execute. “To us, it’s an honor to be recognized once again as a Leader in Gartner’s Magic Quadrant for Unified Endpoint Management Tools,” said Simon Biddiscombe, CEO, MobileIron. “We have continued to innovate and expand upon our UEM platform to keep up with the demands of today’s digital businesses. Earlier this year, we introduced a revolutionary zero sign-on experience to eliminate passwords and make the world’s most ubiquitous product – the mobile device – your ID and secure access to the enterprise built on our leadership foundation in UEM. Mobile and cloud technologies have driven a dramatic change in organizations acr
Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System22.8.2019 09:00:00 EEST | Press release
Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients. The FDA Breakthrough Device designation is intended to speed time to market for treatments of life-threatening or irreversibly debilitating diseases or conditions and recognizes the novelty of the PiCSO Impulse System and its potential to benefit patients with anterior STEMI heart attacks. The Centers for Medicare & Medicaid Services (CMS) also recently acknowledged the importance of this designation by establishing an alternative reimbursement pathway for products that receive FDA marketing authorization and held the Breakthrough Designation. PiCSO therapy is provided by interventional cardiologists during PCI (Percutaneous Coronary Intervention) in patients experiencing ST-elevated myocardial infarction (STEMI). The PiCSO Impulse System clears the coronary microcirculation by intermittently
Mori Building Unveils Massive Urban Regeneration Project in Central Tokyo22.8.2019 07:00:00 EEST | Press release
Mori Building Co., Ltd., a leading urban landscape developer, has begun construction on its “Toranomon-Azabudai District Category 1 Urban Redevelopment Project,” a massive urban regeneration project aimed at revitalizing a large area of central Tokyo. A groundbreaking ceremony was held on August 5 and project completion is scheduled for the end of March 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190821005445/en/ Image of Office Lobby (Graphic: Business Wire) The core concept of the Toranomon-Azabudai Project is that of a “Modern Urban Village,” a unique neighborhood that will combine the sophistication of a megalopolis with the intimacy of a small village in the heart of Tokyo. It will cover an area of approximately 8.1 hectares, similar to that of New York’s Rockefeller Center, and will feature extensive greenery totaling 24,000 m2 including a 6,000 m2 central square. Total floor area will be 860,400 m2, including
Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency22.8.2019 02:01:00 EEST | Press release
STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY As the European distributor of Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin), Mundipharma welcomes the news that the European Medicines Agency (EMA) has accepted the licence extension submission for these two medicines to treat stage 2 or stage 3 chronic kidney disease (CKD) and albuminuria as an adjunct to standard of care in adults with type 2 diabetes mellitus (T2DM). The submission is based on the results from the landmark Phase III CREDENCE study1 which evaluated the efficacy and safety of canagliflozin versus placebo in this high-risk patient population when used in addition to standard of care. “Chronic kidney disease is a serious complication of type 2 diabetes, which can increase patients’ risk of developing end-stage renal disease and may reduce their life expectancy by several years.” said Dr Vinicius Gomes de Lima, European Medical Affairs Lead, Mundipharma. “If approved, this licence
Triton Digital Releases Webcast Metrics Rankings for the Top Digital Audio Properties for April 201921.8.2019 23:00:00 EEST | Press release
Triton Digital®, the global technology and services leader to the digital audio and podcast industry, released today its monthly Webcast Metrics® rankers for April 2019. The global rankers, in addition to the U.S., LATAM, and EMEA regional rankers provide insight into the top-performing streaming audio stations and networks around the world for the month of April. The full results of the Global & Regional Rankers for April 2019 can be found here: https://www.tritondigital.com/resources/monthly-rankers/rankers-archive The Webcast Metrics streaming measurement service is the industry standard for online audio consumption data. It provides credible, validated data that enables audio publishers around the world to analyze the consumption of their audio content by daypart, device type, geography, distribution platform, and more. About Triton Digital Triton Digital® is the global technology and services leader to the digital audio and podcast industry. Operating in more than 40 countries, Tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom